GeneDx Holdings Stock Surges 8% on Strong Q2 Earnings
22
2
BTCCSquare news:
GeneDx Holdings (WGS) saw its shares jump more than 8% after reporting robust second-quarter results, sharply outperforming the broader market's 0.3% decline. Revenue surged 49% year-over-year to $103 million, driven by a 69% increase in exome and genome testing sales. The company also flipped to an adjusted net income of $0.50 per share, far exceeding analyst estimates of $0.12.
Investors cheered the raised full-year guidance, signaling confidence in sustained growth. The genetic testing firm's outperformance highlights the market's appetite for healthcare innovators delivering both top-line expansion and profitability.
By:
Previous
Is Kyrgyzstan Fueling Russia’s Sanctions Evasion Through Crypto?
Next
South Korean Central Bank Establishes Cryptoassets Department Amid Stablecoin Surge
